Compare Abbott Laboratories (ABT) vs Unilever plc (UL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Unilever plc — how do they compare? Abbott Laboratories trades at $95.17 (market cap $166.94B), while Unilever plc trades at $62.07 (market cap $133.28B). The key difference: Abbott Laboratories is the larger of the two by market cap, and Unilever plc pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| ABT | UL | |
|---|---|---|
Market Cap | $166.94B | $133.28B |
Sector | Health | Consumer Staples |
52-Week High | $136.62 | $74.59 |
52-Week Low | $82.57 | $55.05 |
Enterprise Value | $193.69B | $158.73B |
Dividend Yield | 2.63% | 3.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Unilever (UL) trades at $62.74, up 0.42% today, with a bullish technical signal from moving averages. Recent earnings misses contrast with strong profitability margins and a 53.32% ROE. The company is actively reshaping its portfolio through deals like the proposed McCormick food business combination and a $270 million innovation center investment, signaling strategic growth initiatives amid mixed quarterly performance.
UL presents a balanced risk-reward with fair valuation metrics, but faces execution risks from recent earnings shortfalls and portfolio transitions. The analyst community is divided, with a slim majority recommending Hold. Investors should weigh strong cash flow generation against competitive pressures in consumer goods markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
